Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-07-29FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for duloxetine filed by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2022-07-26FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for DULOXETINE submitted by Quallent Pharmaceuticals Health LLC. The notice confirms regulatory …
-
FDA approval · 2022-06-29FDA Approved: VENLAFAXINE — Original Application (Almatica Pharma LLC)
The FDA approved an Original Application for Venlafaxine from Almatica Pharma LLC. Venlafaxine is indicated for major depressive disorder, g…
-
FDA approval · 2022-06-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application from Granules Pharmaceuticals Inc. to approve a bupropion hydrochloride granule formulation unde…
-
FDA approval · 2022-06-27FDA Approved: TRANYLCYPROMINE — Original Application (Solco Healthcare US, LLC)
FDA approves an original application for generic tranylcypromine, a monoamine oxidase inhibitor used for major depressive disorder, manufact…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-06-24FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original application for doxepin hydrochloride as a generic product manufactured by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2022-06-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Slate Run Pharmaceuticals, LLC)
The FDA approved a supplemental application for a generic Bupropion hydrochloride sustained-release product from Slate Run Pharmaceuticals, …
-
FDA approval · 2022-06-16FDA Approved: QUETIAPINE FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic quetiapine fumarate under an Original Application. The product will be used for the same indica…
-
FDA approval · 2022-06-14FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for bupropion hydrochloride from Rising Pharma Holdings, Inc., authorizing the generic product's…
-
FDA approval · 2022-06-08FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for a generic escitalopram oxalate product from Jubilant Cadista Pharmaceuticals Inc., authorizi…
-
FDA approval · 2022-05-27FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole filed by Amneal Pharmaceuticals LLC (generic aripiprazole).
-
FDA approval · 2022-04-26FDA Approved: QUETIAPINE — Original Application (Solco Healthcare U.S., LLC)
The FDA approved the original application for generic quetiapine from Solco Healthcare U.S., LLC.
-
FDA approval · 2022-03-29FDA Approved: FLUOXETINE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for a generic fluoxetine product.
-
FDA approval · 2022-02-25FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, applying to the generic product.
-
FDA approval · 2022-02-09FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (First Nation Group, LLC)
FDA approved the original application for a generic doxepin hydrochloride product from First Nation Group, LLC, enabling its marketing in th…
-
FDA approval · 2022-02-04FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
The FDA approves a supplemental application for CELEXA (citalopram) from Allergan, Inc., updating or expanding the product's labeling.
-
FDA approval · 2022-02-02FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Bupropion hydrochloride as an original-application generic product by Granules Pharmaceuticals Inc.; the product is indicated f…
-
FDA approval · 2022-01-31FDA Approved: CITALOPRAM — Original Application (Almatica Pharma LLC)
FDA approves Citalopram under an Original Application filed by Almatica Pharma LLC. The approval adds Citalopram as a treatment option for m…
-
FDA approval · 2022-01-25FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2022-01-19FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA granted a supplemental approval for paroxetine hydrochloride (paroxetine) from NorthStar Rx LLC under an ANDA. This approval confirm…
-
FDA approval · 2022-01-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Sun Pharmaceutical Industries, authorizing the generic product’s ma…
-
FDA approval · 2022-01-03FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Slate Run Pharmaceuticals, LLC)
The FDA approved a supplemental application for Bupropion Hydrochloride XL from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2022-01-03FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
FDA approves Janssen's supplemental application for SPRAVATO (esketamine) to update its labeling for use in depression.
-
FDA approval · 2021-12-13FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' supplemental application for a sustained-release generic version of bupropion hydrochloride, with the …
-
FDA approval · 2021-12-10FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA has approved a supplemental application for Escitalopram Oxalate from Amneal Pharmaceuticals, indicating an approval of a new generi…